The management challenges of a case with Flupentixol‐induced neuroleptic malignant syndrome

Abstract Background Neuroleptic malignant syndrome (NMS) is a rare and life‐threatening reaction. The incidence rate of NMS has dropped because of the higher use of atypical antipsychotics, compared with the typical ones. The mortality rate in patients taking injectable antipsychotics has been also...

Full description

Bibliographic Details
Main Authors: Forouzan Elyasi, Seyedehnasibeh sadati, Fateme Heydari
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:Neuropsychopharmacology Reports
Subjects:
Online Access:https://doi.org/10.1002/npr2.12315